Puissance Capital Management LP - Oct 13, 2023 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role: 10%+ Owner
Signature: Puissance Life Science Opportunities Fund VI, By: Puissance Capital Fund (GP) LLC, its managing member, By: Theodore T. Wang, Managing Member
Stock symbol: BLPH
Transactions as of: Oct 13, 2023
Transactions value $: -$111,776
Form type: 4
Date filed: 10/16/2023, 08:51 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLPH	Common Stock	Sale	-$112K	-1.08M	-100%	$0.10	0	Oct 13, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Puissance Capital Management LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Fund(GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.